The global pharmacovigilance market grew at a CAGR of around 10% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-26.
Sheridan, United State - August 10, 2021 /MarketersMedia/ —
According to the latest report by IMARC Group, The global pharmacovigilance market grew at a CAGR of around 10% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-26.
Pharmacovigilance (PV) refers to the pharmacological science dealing with the assessment, detection and prevention of unfavorable effects associated with pharmaceutical products. It plays a crucial role in identifying previously unknown adverse effects, recognizing changes in the severity or frequency, and assessing the risks and benefits of drugs to ascertain required actions. PV also certifies the accuracy of communicated information to patients and healthcare professionals. As a result, it is widely used to understand the effects of drugs on individuals worldwide.
Market Trends:
The growing incidences of lifestyle diseases, such as diabetes, hypertension, cardiac disorders, etc., have resulted in the growing consumption of drugs. This, along with the rising cases of adverse drug reactions (ADRs), is primarily driving the market growth. Additionally, the sudden outbreak of COVID-19 has resulted in the urgent need for a vaccine, which has created numerous opportunities for the market players. Moreover, several key manufacturers are introducing advanced platforms to ensure automated ADR reporting, thereby further contributing to the market growth. Besides this, various pharmaceutical manufacturers are increasingly outsourcing pharmacovigilance operations to third parties in order to increase internal resource flexibility and enhance productivity over shorter periods.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/pharmacovigilance-market/requestsample
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Pharmacovigilance Market Coverage and Segmentation 2021-2026:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Accenture plc
ArisGlobal LLC
BioClinica Inc. (Cinven Partners LLP)
Capgemini
Cognizant
International Business Machines Corporation
ICON plc.
IQVIA Inc.
ITClinical
Parexel International Corporation
Wipro Limited.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pharmacovigilance-market
The report has segmented the market on the basis of Product Type, End-User and Region.
Breakup by Service Provider:
In-house
Contract Outsourcing
Breakup by Product Life Cycle:
Pre-clinical
Phase I
Phase II
Phase III
Phase IV
Breakup by Type:
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
Breakup by Process Flow:
Case Data Management
Case Logging
Case Data Analysis
Medical Reviewing and Reporting
Signal Detection
Adverse Event Logging
Adverse Event Analysis
Adverse Event Review and Reporting
Risk Management System
Risk Evaluation System
Risk Mitigation System
Breakup by Therapeutic Area:
Oncology
Neurology
Cardiology
Respiratory Systems
Others
Breakup by End Use:
Pharmaceuticals Companies
Biotechnology Companies
Medical Device Companies
Others
Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Related Reports
Human insulin market: https://www.imarcgroup.com/human-insulin-market
Hemodialysis market: https://www.imarcgroup.com/hemodialysis-market
Hyperlipidemia drugs market: https://www.imarcgroup.com/hyperlipidemia-drugs-market
Blood culture test market: https://www.imarcgroup.com/blood-culture-test-market
GCC e-Health Market: https://www.imarcgroup.com/gcc-e-health-market
Brain Health Supplements Market: https://www.imarcgroup.com/brain-health-supplements-market
Brain Implants Market: https://www.imarcgroup.com/brain-implants-market
Biotech Ingredients Market: https://www.imarcgroup.com/biotech-ingredients-market
Blood Purification Equipment Market: https://www.imarcgroup.com/blood-purification-equipment-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Info:
Name: Elena Anderson
Email: Send Email
Organization: IMARC Group
Address: 30 N Gould St, Ste R Sheridan, WY 82801, United States
Phone: +1-631-791-1145
Website: https://www.imarcgroup.com/
Video URL: https://www.youtube.com/c/Imarcgroup
Source: MarketersMedia
Release ID: 89040939
